It is found that let-7 is significantly upregulated in cerebrospinal fluid of AD patients and is positively correlated with the expression of tau protein, which can be used as a biomarker and an auxiliary means to diagnose AD [68, 69]. The gene discussed is MAPT; the disease is Alzheimer disease.